APA

Lin J., Spidel J. L., Maddage C. J., Rybinski K. A., Kennedy R. P., Krauthauser C. L. M., Park Y. C., Albone E. F., Jacob S., Goserud M. T., Martinez B. P., Chao Q., Zhou Y., Nicolaides N. C., Kline J. B. & Grasso L. (20141007). The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity. : Cancer biology & therapy.

Chicago

Lin JianMin, Spidel Jared L, Maddage Christopher J, Rybinski Katherine A, Kennedy Rina P, Krauthauser Candice L M, Park Young Chul, Albone Earl F, Jacob Sara, Goserud Matthew T, Martinez Bryon P, Chao Qimin, Zhou Yuhong, Nicolaides Nicholas C, Kline J Bradford and Grasso Luigi. 20141007. The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity. : Cancer biology & therapy.

Harvard

Lin J., Spidel J. L., Maddage C. J., Rybinski K. A., Kennedy R. P., Krauthauser C. L. M., Park Y. C., Albone E. F., Jacob S., Goserud M. T., Martinez B. P., Chao Q., Zhou Y., Nicolaides N. C., Kline J. B. and Grasso L. (20141007). The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity. : Cancer biology & therapy.

MLA

Lin JianMin, Spidel Jared L, Maddage Christopher J, Rybinski Katherine A, Kennedy Rina P, Krauthauser Candice L M, Park Young Chul, Albone Earl F, Jacob Sara, Goserud Matthew T, Martinez Bryon P, Chao Qimin, Zhou Yuhong, Nicolaides Nicholas C, Kline J Bradford and Grasso Luigi. The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity. : Cancer biology & therapy. 20141007.